Share
9 hours ago
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
4 hours ago
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
Tags: US cancer treatment firm Nuvalent, cancer biotech Nuvalent, GSK, talks,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines